semaglutide fatty liver disease effectively treats in two thirds of patients, research finds Resmetirom and semaglutide in metabolic

Providers generally initiate one agent first, assess tolerance, then add the second at low dose with regular follow-ups

Dose adjustments depend on clinical markers including skin thickness, collagen expression indicators, and localized tissue response at injection sites

Changes are expected to become more evident after the second treatment takes full effect

However, the medications have gained popularity and credibility in recent years for their ability to help reduce weight in obese adults WITHOUT Diabetes Type 2

[1] -

No Impact on blood glucose: One of the most significant benefits of allulose is its minimal impact on blood glucose levels